|
NDC00364-2390-06
|
6505-01-304-1652
|
Prazosin Hydrochloride Capsules |
Schein Henry Inc
|
|
Quote
|
|
NDC00364-2391-06
|
6505-01-304-1653
|
Prazosin Hydrochloride Capsules |
Schein Henry Inc
|
|
Quote
|
|
OCL SOLUTION
|
6505-01-304-2159
|
Colonic Lavage Oral Solution |
Abbott Laboratories Inc.
|
|
Quote
|
|
A89E047
|
6505-01-304-2159
|
Colonic Lavage Oral Solution |
Department of the Army
|
|
Quote
|
|
NDC00074-9099-16
|
6505-01-304-2159
|
Colonic Lavage Oral Solution |
Abbott Laboratories Inc.
|
|
Quote
|
|
ADRIAMYCIN PF5
|
6505-01-304-2164
|
Doxorubicin Hydrochloride Inject |
Action Business Corp
|
|
Quote
|
|
NDC00013-1166-83
|
6505-01-304-2164
|
Doxorubicin Hydrochloride Inject |
Erbamont Inc
|
|
Quote
|
|
NDC00703-5040-01
|
6505-01-304-2164
|
Doxorubicin Hydrochloride Inject |
Sicor Pharmaceuticals Sales Inc
|
|
Quote
|
|
A1166-01
|
6505-01-304-2164
|
Doxorubicin Hydrochloride Inject |
Abbott Laboratories Inc
|
|
Quote
|
|
NDC00074-1166-01
|
6505-01-304-2164
|
Doxorubicin Hydrochloride Inject |
Abbott Laboratories Inc
|
|
Quote
|
|
NDC55390-0246-10
|
6505-01-304-2164
|
Doxorubicin Hydrochloride Inject |
Mova Pharmaceutical Corp
|
|
Quote
|
|
NDC55390-0248-01
|
6505-01-304-2164
|
Doxorubicin Hydrochloride Inject |
Mova Pharmaceutical Corp
|
|
Quote
|
|
NDC55390-0236-10
|
6505-01-304-2164
|
Doxorubicin Hydrochloride Inject |
Falcon Pharmaceuticals Ltd
|
|
Quote
|
|
NDC55390-0238-01
|
6505-01-304-2164
|
Doxorubicin Hydrochloride Inject |
Falcon Pharmaceuticals Ltd
|
|
Quote
|
|
2G3504
|
6505-01-304-4964
|
Usp Cefriaxone Injection |
Baxter Healthcare Corporation
|
|
Quote
|
|
A89F002
|
6505-01-304-4968
|
Usp Ascorbic Acid Injection |
Department of the Army
|
|
Quote
|
|
CEVALIN
|
6505-01-304-4968
|
Usp Ascorbic Acid Injection |
Lilly Eli and Co Inc
|
|
Quote
|
|
NDC00002-1677-25
|
6505-01-304-4968
|
Usp Ascorbic Acid Injection |
Lilly Eli and Co Inc
|
|
Quote
|
|
F89F309
|
6505-01-304-4969
|
Modifie Docusate Sodium Solution |
Air Force Medical Logistics Office
|
|
Quote
|
|
NDC00536-0590-85
|
6505-01-304-4969
|
Modifie Docusate Sodium Solution |
Rugby Group Inc
|
|
Quote
|
|
6020590
|
6505-01-304-4969
|
Modifie Docusate Sodium Solution |
Rugby Group Inc
|
|
Quote
|
|
A89F015
|
6505-01-304-4971
|
Esmolol Hydrochloride Injection |
Department of the Army
|
|
Quote
|
|
BREVIBLOC
|
6505-01-304-4971
|
Esmolol Hydrochloride Injection |
Anaquest
|
|
Quote
|
|
NDC10019-0015-71
|
6505-01-304-4971
|
Esmolol Hydrochloride Injection |
Anaquest
|
|
Quote
|
|
BREVIBLOC INJECTION
|
6505-01-304-4971
|
Esmolol Hydrochloride Injection |
Anaquest
|
|
Quote
|
|
NDC00590-0015-71
|
6505-01-304-4971
|
Esmolol Hydrochloride Injection |
Anaquest
|
|
Quote
|
|
NDC00364-2389-06
|
6505-01-304-6412
|
Prazosin Hydrochloride Capsules |
Schein Henry Inc
|
|
Quote
|
|
NDC00364-2390-05
|
6505-01-304-6413
|
Prazosin Hydrochloride Capsules |
Schein Henry Inc
|
|
Quote
|
|
SANDOSTATIN
|
6505-01-304-7216
|
Octreotide Acetate Injection |
Novartis Pharmaceuticals Corporation
|
|
Quote
|
|
NDC00078-0180-03
|
6505-01-304-7216
|
Octreotide Acetate Injection |
Novartis Pharmaceuticals Corporation
|
|
Quote
|
|
SANDOSTATIN
|
6505-01-304-7217
|
Octreotide Acetate Injection |
Novartis Pharmaceuticals Corporation
|
|
Quote
|
|
NDC00078-0180-04
|
6505-01-304-7217
|
Octreotide Acetate Injection |
Novartis Pharmaceuticals Corporation
|
|
Quote
|
|
SANDOSTATIN
|
6505-01-304-7218
|
Octreotide Acetate Injection |
Novartis Pharmaceuticals Corporation
|
|
Quote
|
|
NDC00078-0181-04
|
6505-01-304-7218
|
Octreotide Acetate Injection |
Novartis Pharmaceuticals Corporation
|
|
Quote
|
|
H10298
|
6505-01-304-7218
|
Octreotide Acetate Injection |
Barenboim Cia Ltda
|
|
Quote
|
|
SANDOSTATIN
|
6505-01-304-7220
|
Octreotide Acetate Injection |
Novartis Pharmaceuticals Corporation
|
|
Quote
|
|
NDC00078-0181-03
|
6505-01-304-7220
|
Octreotide Acetate Injection |
Novartis Pharmaceuticals Corporation
|
|
Quote
|
|
0332-59
|
6505-01-304-9017
|
And Simethicone Magnesia Alumina |
Aventis Pharmaceuticals Products
|
|
Quote
|
|
NDC00067-0332-79
|
6505-01-304-9017
|
And Simethicone Magnesia Alumina |
Aventis Pharmaceuticals Products
|
|
Quote
|
|
MAALOX PLUS SUSP
|
6505-01-304-9017
|
And Simethicone Magnesia Alumina |
Aventis Pharmaceuticals Products
|
|
Quote
|
|
BETAGAN
|
6505-01-304-9761
|
Levobunolol Hydrochloride Ophtha |
Allergan Inc
|
|
Quote
|
|
BETAGAN C CAP QD
|
6505-01-304-9761
|
Levobunolol Hydrochloride Ophtha |
Allergan Inc
|
|
Quote
|
|
NDC11980-0252-65
|
6505-01-304-9761
|
Levobunolol Hydrochloride Ophtha |
Allergan Inc
|
|
Quote
|
|
NDC24208-0505-05
|
6505-01-304-9761
|
Levobunolol Hydrochloride Ophtha |
Bausch & Lomb Pharmaceuticals
|
|
Quote
|
|
NDC00364-3039-53
|
6505-01-304-9761
|
Levobunolol Hydrochloride Ophtha |
Schein Pharmaceutical Inc
|
|
Quote
|
|
CEFADYL
|
6505-01-305-0461
|
Usp Cephapirin Sodium |
Bristol-myers Squibb Pharmaceutical
|
|
Quote
|
|
NDC00015-7628-22
|
6505-01-305-0461
|
Usp Cephapirin Sodium |
Bristol-myers Squibb Pharmaceutical
|
|
Quote
|
|
NDC49452-4050-02
|
6505-01-305-1166
|
Usp Lidocaine Hydrochloride |
Spectrum Laboratory Products, Inc.
|
|
Quote
|
|
NDC58406-0623-07
|
6505-01-305-1167
|
Leucovorin Calcium For Injection |
Amgen Inc.
|
|
Quote
|
|
NDC87701-0402-44
|
6505-01-305-1170
|
Magnesium Citrate Oral Solution |
Aaron Industries Inc
|
|
Quote
|
|
NDC00395-0600-10
|
6505-01-305-1170
|
Magnesium Citrate Oral Solution |
Amerisourcebergen Drug Corporation
|
|
Quote
|
|
F89E508
|
6505-01-305-1170
|
Magnesium Citrate Oral Solution |
Air Force Medical Logistics Office
|
|
Quote
|
|
NDC00869-0693-38
|
6505-01-305-1170
|
Magnesium Citrate Oral Solution |
Aaron Labs
|
|
Quote
|
|
NDC00395-0600-10
|
6505-01-305-1170
|
Magnesium Citrate Oral Solution |
Walmead Inc
|
|
Quote
|
|
0332-56
|
6505-01-305-3136
|
And Simethicone Magnesia Alumina |
Aventis Pharmaceuticals Products
|
|
Quote
|
|
NDC00067-0332-22
|
6505-01-305-3136
|
And Simethicone Magnesia Alumina |
Aventis Pharmaceuticals Products
|
|
Quote
|
|
MAALOX PLUS SUSP
|
6505-01-305-3136
|
And Simethicone Magnesia Alumina |
Aventis Pharmaceuticals Products
|
|
Quote
|
|
ROXICODONE
|
6505-01-305-3145
|
Oxycodone Hydrochloride Tablets |
Boehringer Ingelheim Roxane, Inc.
|
|
Quote
|
|
NDC00054-4657-25
|
6505-01-305-3145
|
Oxycodone Hydrochloride Tablets |
Boehringer Ingelheim Roxane, Inc.
|
|
Quote
|
|
NDC00378-6112-01
|
6505-01-305-3145
|
Oxycodone Hydrochloride Tablets |
Mylan Pharmaceuticals Inc.
|
|
Quote
|
|
6505NCM151646
|
6505-01-305-3145
|
Oxycodone Hydrochloride Tablets |
Defense Medical Standardization
|
|
Quote
|
|
1281891
|
6505-01-305-3145
|
Oxycodone Hydrochloride Tablets |
Defense Logistics Agency
|
|
Quote
|
|
NDC57664-0223-88
|
6505-01-305-3145
|
Oxycodone Hydrochloride Tablets |
Caraco Pharmaceutical Laboratories,
|
|
Quote
|
|
NDC00078-0078-05
|
6505-01-305-4523
|
Nortriptyline Hydrochloride Caps |
Novartis Pharmaceuticals Corporation
|
|
Quote
|
|
PAMELOR
|
6505-01-305-4523
|
Nortriptyline Hydrochloride Caps |
Novartis Pharmaceuticals Corporation
|
|
Quote
|
|
NDC00026-0601-30
|
6505-01-305-4683
|
Hum Alpha-1-proteinase Inhibitor |
Talecris Biotherapeutics Holdings
|
|
Quote
|
|
NDC00026-0601-30
|
6505-01-305-4683
|
Hum Alpha-1-proteinase Inhibitor |
Bayer Pharmaceuticals Corporation
|
|
Quote
|
|
VASOTEC IV
|
6505-01-305-6988
|
Enalaprilat Injection |
Merck Sharp & Dohme Corp.
|
|
Quote
|
|
NDC00006-3508-04
|
6505-01-305-6988
|
Enalaprilat Injection |
Merck Sharp & Dohme Corp.
|
|
Quote
|
|
NDC10019-0092-04
|
6505-01-305-6988
|
Enalaprilat Injection |
Baxter Healthcare Corp
|
|
Quote
|
|
NDC10019-0095-04
|
6505-01-305-6988
|
Enalaprilat Injection |
Baxter Healthcare Corp
|
|
Quote
|
|
NDC61703-0237-16
|
6505-01-305-6988
|
Enalaprilat Injection |
Faulding Pharmaceuticals
|
|
Quote
|
|
NDC00074-2122-02
|
6505-01-305-6988
|
Enalaprilat Injection |
Abbott Laboratories Inc
|
|
Quote
|
